Agitation in cognitive disorders: progress in the International Psychogeriatric Association consensus clinical and research definition.
Open accessThe DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The International Psychogeriatric Association (IPA) published a provisional consensus definition of agitation in cognitive disorders in 2015. As proposed by the original work group, we summarize the use and validation of criteria in order to remove "provisional" from the definition. METHODS: This report summarizes information from the academic literature, research resources, clinical guidelines, expert surveys, and patient and family advocates on the experience of use of the IPA definition. The information was reviewed by a working group of topic experts to create a finalized definition. RESULTS: We present a final definition which closely resembles the provisional definition with modifications to address special circumstances. We also summarize the development of tools for diagnosis and assessment of agitation and propose strategies for dissemination and integration into precision diagnosis and agitation interventions. CONCLUSION: The IPA definition of agitation captures a common and important entity that is recognized by many stakeholders. Dissemination of the definition will permit broader detection and can advance research and best practices for care of patients with agitation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Behavioral and psychiatric symptoms of dementia (BPSD; another term: neuropsychiatric symptoms [NPS]), are prevalent in AD and include agitation, depression, apathy, psychosis, anxiety, aggression, disinhibition, and sleep disturbances.33,34”
From A 2025 update on treatment strategies for the Alzheimer’s disease spectrum (2025) · cites this paper as [34]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hirono, N., Mori, E., Ikejiri, Y., Imamura, T., Shimomura, T., Hashimoto, M., Yamashita, H., & Ikeda, M. (1997) · Brain and nerve · Cited by 21,038
Kok, J. S., Berg, I. J., & Scherder, E. J. A. (2013) · Dementia and Geriatric Cognitive Disorders Extra · doi:10.1159/000353441 · Cited by 20,589
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Self-citationAgitated Behaviors in the Elderly: I. A Conceptual Review
Cohen‐Mansfield, J., & Billig, N. (1986) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1986.tb04302.x · Cited by 717
The interface between delirium and dementia in elderly adults
Fong, T. G., Davis, D., Growdon, M. E., Albuquerque, A., & Inouye, S. K. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)00101-5 · Cited by 595 · cited 2×
“Delirium is common among agitated hospitalized patients; dementia is a risk factor for delirium, and delirium is a risk factor for subsequent development of dementia (Fong et al. , 2015).”
BackgroundKales, H. C., Gitlin, L. N., Lyketsos, C. G., & Dementia, T. D. E. P. O. T. A. A. M. O. T. N. S. O. (2014) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12730 · Cited by 575
Two types of aggression in human evolution.
Wrangham, R. W. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1713611115 · Cited by 410 · cited 2×
“Reactive and proactive types of aggression have been identi fi ed (Wrangham, 2018).”
BackgroundCummings, J., Mintzer, J., Brodaty, H., Sano, M., Banerjee, S., Devanand, D. P., Gauthier, S., Howard, R., Lanctôt, K., Lyketsos, C. G., et al. (2015) · International Psychogeriatrics · doi:10.1017/s1041610214001963 · Cited by 355
Self-citationKatz, D. I., Bernick, C., Dodick, D. W., Mez, J., Mariani, M. L., Adler, C. H., Alosco, M. L., Balcer, L. J., Banks, S. J., Barr, W. B., et al. (2021) · Neurology · doi:10.1212/wnl.0000000000011850 · Cited by 337
Self-citationHan, J. H., Wilson, A., Vasilevskis, E. E., Shintani, A., Schnelle, J. F., Dittus, R. S., Graves, A. J., Storrow, A. B., Shuster, J., & Ely, E. W. (2013) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2013.05.003 · Cited by 329
Cited by
Brexpiprazole for the Treatment of Agitation in Alzheimer Dementia: A Randomized Clinical Trial
Lee, D., Slomkowski, M., Hefting, N., Chen, D., Larsen, K. G., Kohegyi, E., Hobart, M., Cummings, J. L., & Grossberg, G. T. (2023) · JAMA Neurology · doi:10.1001/jamaneurol.2023.3810 · Cited by 135
Self-citationA 2025 update on treatment strategies for the Alzheimer’s disease spectrum
Wu, C.-K., & Fuh, J.-L. (2025) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000001252 · Cited by 77
“35 Both typical (eg, haloperidol) and atypical (eg, risperidone, quetiapine) antipsychotics are used but they both come with significant risks such as sedation and increased mortality.”
Cummings, J. L., Lanctôt, K. L., Grossberg, G. T., & Ballard, C. G. (2024) · JAMA Neurology · doi:10.1001/jamaneurol.2024.0586 · Cited by 53
Self-citationNeuropsychiatric symptoms in spinocerebellar ataxias and Friedreich ataxia
Karamazovová, S., Matušková, V., Ismail, Z., & Vyhnálek, M. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105205 · Cited by 50
Self-citationBrexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study
Nakamura, Y., Adachi, J., Hirota, N., Iba, K., Shimizu, K., Nakai, M., Takahashi, K., & Mori, N. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14282 · Cited by 36
“…the baseline assessment, and continuous or frequent recurrence of agitation affecting daily life for ≥ 2 weeks before both the screening test and the baseline assessment (the definition of agitation was in accordance with the International Psy-chogeriatric Association’s consensus definition 2 ).”
Metadata
- Authors
- Sano, M., Cummings, J., Auer, S., Bergh, S., Fischer, C. E., Gerritsen, D., Grossberg, G., Ismail, Z., Lanctôt, K., Lapid, M. I., Mintzer, J., Palm, R., Rosenberg, P. B., Splaine, M., Zhong, K., & Zhu, C. W.
- Affiliations
- James J. Peters VA Medical Center (US)
- University of Nevada, Las Vegas (US)
- Universität für Weiterbildung Krems (AT)
- Innlandet Hospital Trust (NO)
- University of Toronto (CA)
- Radboud University Medical Center (NL)
- Saint Louis University (US)
- University of Calgary (CA)
- Mayo Clinic (US)
- Medical University of South Carolina (US)
- Witten/Herdecke University (DE)
- Johns Hopkins University (US)
- Corresponding author
- Sano, Mary
- ORCID
- Venue
- International Psychogeriatrics
- Publisher
- Elsevier BV
- Published
- 2024-04
- Volume
- 36
- Issue
- 4
- Pages
- 238-250
- ISSN
- 1041-6102 (ISSN-L)
- PMC
- PMC10684256
- OpenAlex
- W4323348598
- Cited by
- 91
- References
- 53
- Citations by year
- 2026: 33 · 2025: 30 · 2024: 14
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- International Psychogeriatrics (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by)
- Funders
- Alzheimer's Drug Discovery Foundation (P20GM109025)
- Eli Lilly and Company (P20GM109025)
- Biogen (P20GM109025)
- Fondation Brain Canada
- Jazz Pharmaceuticals
- ACADIA Pharmaceuticals
- Prothena
- Austrian Science Fund
- Eisai (P20GM109025)
- Novo Nordisk
- H. Lundbeck A/S (P20GM109025)
- Grifols
- National Institutes of Health
- Health Resources and Services Administration
- Genentech (P20GM109025)
- National Institute on Aging (R01AG050515, U01AG016976, R01AG053798, P20AG068053, R01AG054771, R01AG051545, R01AG061100, R35AG71476, P30AG072959, P30AG066514, U24AG072122, R35AG071476)
- National Institute of General Medical Sciences (P20GM109025)
- National Institute of Neurological Disorders and Stroke (U01NS093334)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- agitation, cognitive disorders, dementia, consensus definition, diagnostic criteria, precision diagnostics, stakeholder validation
- MeSH terms
- Cognition Disorders, Consensus Statements as Topic, Geriatric Psychiatry, Humans, Psychomotor Agitation, Consensus, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Agitation in cognitive disorders: progress in the International Psychogeriatric Association consensus clinical and research definition. https://app.cochat.ai/papers/10.1017/s1041610222001041
- The paper
- Sano, M., Cummings, J., Auer, S., Bergh, S., Fischer, C. E., Gerritsen, D., Grossberg, G., Ismail, Z., Lanctôt, K., Lapid, M. I., Mintzer, J., Palm, R., Rosenberg, P. B., Splaine, M., Zhong, K., & Zhu, C. W. (2024). Agitation in cognitive disorders: progress in the International Psychogeriatric Association consensus clinical and research definition. International Psychogeriatrics. https://doi.org/10.1017/s1041610222001041
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
